iSOFT Launches Web-Based E-Prescribing Solution for the NHS

iSOFT Group LimitediSOFT Group Limited (ASX:ISF) has launched a new e-prescribing and medication administration (ePMA) solution in the UK and is close to finalising deals with a number of NHS trusts to become early adopters.

The solution is already used at ten hospitals in Australia and across six district health boards in New Zealand for safer and more efficient medicines management. Users report sharp falls in incidents due to drugs being wrongly prescribed or doses being missed. And incidents due to illegible scripts are a thing of the past.

Working with First DataBank, a leading provider of drug databases and active clinical decision support, iSOFT has adapted the solution for the UK market. It offers a drug formulary and decision support rules engine to stop drugs being wrongly prescribed and so shorten hospital stays. It will also streamline processes such as discharge, reduce re-admission rates, and cut costs.

"We have a very strong, if not unique, proposition in combining the scale and capability of iSOFT to deliver a best of breed ePMA solution," said Adrian Stevens, Managing Director of iSOFT's UK and Ireland business.

"This is also very timely following the recent publication of the UK government's white paper, Equity and Excellence: Liberating the NHS, which highlights the importance of improving healthcare outcomes and patient safety.

"Last year, the National Patient Safety Agency reported that more than 200 patients every month need further treatment or die because of medication mistakes. Our ePMA solution can help to drastically reduce this statistic."

The solution is specifically designed to allow NHS trusts that have already invested in elements of an electronic patient record to introduce a fully integrated and comprehensive ePMA solution.

Mark Treleaven, Sales and Marketing Director, First DataBank said: "It is clear that iSOFT's new solution has been designed to meet the specialist requirements of prescribing and administering medicines. As such, we are very excited to see our product associated with an initiative that will make full use of the Multilex DDF sophistication."

The first early adopter sites are expected to go-live in 2011. The software will be exhibited at various events throughout the year including E-Health Insider Live in November.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in over 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists in 19 countries worldwide, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...